Table 2 Incidence of Treatment-Related AEs Reported by ≥1% of Patients
MF-DPI 400 μg QD PM (n = 611) | MF-DPI 200 μg BID (n = 622) | |
|---|---|---|
Patients reporting any AE, n (%) | 85 (14) | 109 (18) |
Headache | 10 (2) | 12 (2) |
Dysphonia | 3 (<1) | 9 (1) |
Mouth dry | 12 (2) | 11 (2) |
Mouth ulceration | 5 (1) | 1 (<1) |
Candidiasis, oral | 9 (1) | 16(3) |
Pharyngitis | 16 (3) | 15 (2) |
Upper respiratory tract infection | 5 (1) | 0 |
Cough | 2 (<1) | 6 (1) |
Hoarseness | 4 (1) | 5 (1) |
Throat dry | 11 (2) | 3 (<1) |
Rash | 0 | 4 (1) |